The market for organ preservation solutions is driven by rising transplant surgeries due to chronic illnesses and aging ...

Bridge to Life has received FDA De Novo clearance for its VitaSmart hypothermic oxygenated perfusion (HOPE) system for liver ...

The FDA clearance enables the commercial use of VitaSmart (TM) for hypothermic oxygenated perfusion of donor livers following static cold storage and prior to transplantation, providing a clear, ...

A clinical study shows that preoperative dynamic susceptibility contrast (DSC) perfusion magnetic resonance imaging (MRI) can ...

Normothermic machine perfusion (NMP) to preserve livers prior to transplant was associated with significantly improved clinical outcomes and reduced use of hospital resources compared with static cold ...

The latest tweak to fair value and what it signals The fair value estimate for Xvivo Perfusion has been trimmed slightly from SEK 319.6 to SEK 317.6, with a modestly higher discount rate and a small ...

A study led by scientists at the Centro Nacional de Investigaciones Carlos III (CNIC) demonstrates that stroke severity ...

Potential for improved product quality and cost/time savings is reviving interest in perfusion technology. Tuomas Kujansuu/E+/Getty Images Perfusion technology was first introduced in the late 1980s ...

In OHCA survivors, longer elevated perfusion pressure duration with MAP >80 mmHg in the first 48 hours after ROSC was ...

Bridge to Life™ Ltd., a global innovator in organ preservation and perfusion technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo clearance for the ...